About: Amdoxovir

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Amdoxovir is a pharmaceutical drug that has undergone research for the treatment of HIV/AIDS. It acts as a nucleoside reverse transcriptase inhibitor (NRTI). The drug was discovered by Raymond F. Schinazi (Emory University) and C.K. Chu (University of Georgia) and developed by . Amdoxovir was in advanced Phase II clinical trials around 2010. In 2013, a Phase II trial was terminated and another was withdrawn before it started. No further studies appear to have been done.

Property	Value
dbo:abstract	Amodxovir ist ein experimenteller Arzneistoff zur Behandlung HIV-infizierter Patienten im Rahmen einer HIV-Kombinationstherapie. Amodxovir gehört zur Gruppe der nukleosidischen Reverse-Transkriptase-Inhibitoren (NRTI). (de) Amdoxovir is a pharmaceutical drug that has undergone research for the treatment of HIV/AIDS. It acts as a nucleoside reverse transcriptase inhibitor (NRTI). The drug was discovered by Raymond F. Schinazi (Emory University) and C.K. Chu (University of Georgia) and developed by . Amdoxovir was in advanced Phase II clinical trials around 2010. In 2013, a Phase II trial was terminated and another was withdrawn before it started. No further studies appear to have been done. (en)
dbo:casNumber	145514-04-1
dbo:chEMBL	458876
dbo:fdaUniiCode	54I81H0M9C
dbo:kegg	D02890
dbo:pubchem	124088
dbo:thumbnail	wiki-commons:Special:FilePath/Amdoxovir.svg?width=300
dbo:wikiPageID	15564595 (xsd:integer)
dbo:wikiPageLength	3483 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1021890044 (xsd:integer)
dbo:wikiPageWikiLink	dbc:Dioxolanes dbr:University_of_Georgia dbc:Experimental_drugs dbc:Purines dbr:Emory_University dbc:Hydroxymethyl_compounds dbr:HIV/AIDS dbc:Nucleoside_analog_reverse_transcriptase_inhibitors dbr:Raymond_F._Schinazi dbr:Phase_II_clinical_trial dbr:Nucleoside_reverse_transcriptase_inhibitor dbr:RFS_Pharma
dbp:atcPrefix	none (en)
dbp:c	9 (xsd:integer)
dbp:casNumber	145514 (xsd:integer)
dbp:chembl	458876 (xsd:integer)
dbp:chemspiderid	110576 (xsd:integer)
dbp:h	12 (xsd:integer)
dbp:iupacName	[-4--1,3-dioxolan-2-yl]methanol (en)
dbp:kegg	D02890 (en)
dbp:n	6 (xsd:integer)
dbp:niaidChemdb	5431 (xsd:integer)
dbp:o	3 (xsd:integer)
dbp:pubchem	124088 (xsd:integer)
dbp:smiles	n2c1cN (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	RLAHNGKRJJEIJL-RFZPGFLSSA-N (en)
dbp:unii	54 (xsd:integer)
dbp:verifiedrevid	437146369 (xsd:integer)
dbp:watchedfields	changed (en)
dbp:wikiPageUsesTemplate	dbt:Infobox_drug dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Ebicite dbt:Fdacite dbt:Keggcite dbt:Stdinchicite dbt:Antiretroviral_drug dbt:Antiinfective-drug-stub
dcterms:subject	dbc:Dioxolanes dbc:Experimental_drugs dbc:Purines dbc:Hydroxymethyl_compounds dbc:Nucleoside_analog_reverse_transcriptase_inhibitors
gold:hypernym	dbr:Inhibitor
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatMolecularFormulas yago:WikicatNucleosideAnalogReverseTranscriptaseInhibitors yago:Abstraction100002137 yago:Agent114778436 yago:Antiviral102725367 yago:CausalAgent100007347 yago:Communication100033020 yago:Drug103247620 yago:Formula106816935 yago:Matter100020827 yago:Medicine103740161 yago:Message106598915 yago:MolecularFormula106817173 yago:PhysicalEntity100001930 dbo:Drug yago:ReverseTranscriptaseInhibitor104085365 yago:Statement106722453 yago:Substance100020090 yago:WikicatReverseTranscriptaseInhibitors umbel-rc:DrugProduct
rdfs:comment	Amodxovir ist ein experimenteller Arzneistoff zur Behandlung HIV-infizierter Patienten im Rahmen einer HIV-Kombinationstherapie. Amodxovir gehört zur Gruppe der nukleosidischen Reverse-Transkriptase-Inhibitoren (NRTI). (de) Amdoxovir is a pharmaceutical drug that has undergone research for the treatment of HIV/AIDS. It acts as a nucleoside reverse transcriptase inhibitor (NRTI). The drug was discovered by Raymond F. Schinazi (Emory University) and C.K. Chu (University of Georgia) and developed by . Amdoxovir was in advanced Phase II clinical trials around 2010. In 2013, a Phase II trial was terminated and another was withdrawn before it started. No further studies appear to have been done. (en)
rdfs:label	Amdoxovir (de) Amdoxovir (en)
owl:sameAs	freebase:Amdoxovir yago-res:Amdoxovir wikidata:Amdoxovir dbpedia-de:Amdoxovir dbpedia-sh:Amdoxovir dbpedia-sr:Amdoxovir dbpedia-vi:Amdoxovir https://global.dbpedia.org/id/4GWk5
prov:wasDerivedFrom	wikipedia-en:Amdoxovir?oldid=1021890044&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Amdoxovir.svg
foaf:isPrimaryTopicOf	wikipedia-en:Amdoxovir
is dbo:wikiPageRedirects of	dbr:C9H12N6O3
is dbo:wikiPageWikiLink of	dbr:C9H12N6O3 dbr:Discovery_and_development_of_nucleosid...tide_reverse-transcriptase_inhibitors dbr:List_of_drugs:_Am
is foaf:primaryTopic of	wikipedia-en:Amdoxovir